| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Chiara Russo, Franziska Ferk, Miroslav Mišík, Nathalie Ropek, Armen Nersesyan, Doris Mejri, Klaus Holzmann, Margherita Lavorgna, Marina Isidori, Siegfried Knasmülle. Low doses of widely consumed cannabinoids (cannabidiol and cannabidivarin) cause DNA damage and chromosomal aberrations in human-derived cells. Archives of toxicology. vol 93. issue 1. 2020-03-04. PMID:30341733. |
low doses of widely consumed cannabinoids (cannabidiol and cannabidivarin) cause dna damage and chromosomal aberrations in human-derived cells. |
2020-03-04 |
2023-08-13 |
mouse |
| Chiara Russo, Franziska Ferk, Miroslav Mišík, Nathalie Ropek, Armen Nersesyan, Doris Mejri, Klaus Holzmann, Margherita Lavorgna, Marina Isidori, Siegfried Knasmülle. Low doses of widely consumed cannabinoids (cannabidiol and cannabidivarin) cause DNA damage and chromosomal aberrations in human-derived cells. Archives of toxicology. vol 93. issue 1. 2020-03-04. PMID:30341733. |
cannabidiol (cbd) and cannabidivarin (cbdv) are natural cannabinoids which are consumed in increasing amounts worldwide in cannabis extracts, as they prevent epilepsy, anxiety, and seizures. |
2020-03-04 |
2023-08-13 |
mouse |
| Rebecca Thompson, Katherine DeJong, Jamie L. Marijuana Use in Pregnancy: A Review. Obstetrical & gynecological survey. vol 74. issue 7. 2020-03-03. PMID:31343707. |
the main active chemical of marijuana (delta-9-tetrahydrocannabinol [thc]) readily crosses the placenta, and cannabinoid receptors have been identified in fetal brain and placenta. |
2020-03-03 |
2023-08-13 |
Not clear |
| Hery Chung, Angélica Fierro, C David Pessoa-Mahan. Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study. PloS one. vol 14. issue 7. 2020-02-26. PMID:31335889. |
cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: an in silico study. |
2020-02-26 |
2023-08-13 |
Not clear |
| Hery Chung, Angélica Fierro, C David Pessoa-Mahan. Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study. PloS one. vol 14. issue 7. 2020-02-26. PMID:31335889. |
recent evidence has raised in discussion the possibility that cannabidiol can act as a negative allosteric modulator of the cannabinoid type 1 receptor. |
2020-02-26 |
2023-08-13 |
Not clear |
| Michael Kraemer, Burkhard Madea, Cornelius Hes. Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use? Drug testing and analysis. vol 11. issue 10. 2020-02-26. PMID:31407526. |
detectability of various cannabinoids in plasma samples of cannabis users: indicators of recent cannabis use? |
2020-02-26 |
2023-08-13 |
Not clear |
| Michael Kraemer, Burkhard Madea, Cornelius Hes. Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use? Drug testing and analysis. vol 11. issue 10. 2020-02-26. PMID:31407526. |
to assess the informative value of determining (minor) cannabinoids in plasma of cannabis users, detection rates of 14 cannabinoids (next to Δ |
2020-02-26 |
2023-08-13 |
Not clear |
| Roberta Pacifici, Emilia Marchei, Francesco Salvatore, Luca Guandalini, Francesco Paolo Busardò, Simona Pichin. Stability of cannabinoids in cannabis FM1 flowering tops and oil preparation evaluated by ultra-high performance liquid chromatography tandem mass spectrometry. Clinical chemistry and laboratory medicine. vol 57. issue 7. 2020-02-25. PMID:30472696. |
stability of cannabinoids in cannabis fm1 flowering tops and oil preparation evaluated by ultra-high performance liquid chromatography tandem mass spectrometry. |
2020-02-25 |
2023-08-13 |
Not clear |
| Dawn E Sugarman, Joao P De Aquino, James Poling, Mehmet Sofuogl. Feasibility and effects of galantamine on cognition in humans with cannabis use disorder. Pharmacology, biochemistry, and behavior. vol 181. 2020-02-25. PMID:31082417. |
as long-term use of medicinal and recreational cannabis becomes more common and concentrations of delta-9-tetrahydrocannabinol (thc) in cannabis increase, it is timely to identify strategies to counteract the cognitive effects of cannabinoids. |
2020-02-25 |
2023-08-13 |
Not clear |
| Laura Orsolini, Stefania Chiappini, Umberto Volpe, Domenico De Berardis, Roberto Latini, Gabriele Duccio Papanti, And John Martin Corker. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. Medicina (Kaunas, Lithuania). vol 55. issue 9. 2020-02-24. PMID:31450833. |
use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (ptsd): a systematic review. |
2020-02-24 |
2023-08-13 |
Not clear |
| Laura Orsolini, Stefania Chiappini, Umberto Volpe, Domenico De Berardis, Roberto Latini, Gabriele Duccio Papanti, And John Martin Corker. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. Medicina (Kaunas, Lithuania). vol 55. issue 9. 2020-02-24. PMID:31450833. |
despite several therapeutic approaches being available, both pharmacological and psychological, recently a growing interest has developed in using cannabis and synthetic cannabinoids stems from their consideration as more efficient and better tolerated alternatives for the treatment of this condition. |
2020-02-24 |
2023-08-13 |
Not clear |
| Laura Orsolini, Stefania Chiappini, Umberto Volpe, Domenico De Berardis, Roberto Latini, Gabriele Duccio Papanti, And John Martin Corker. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. Medicina (Kaunas, Lithuania). vol 55. issue 9. 2020-02-24. PMID:31450833. |
the present paper aims to evaluate the clinical and therapeutic potentials of medical cannabis and synthetic cannabinoids in treating ptsd patients. |
2020-02-24 |
2023-08-13 |
Not clear |
| Lutfun Nahar, Mingquan Guo, Satyajit D Sarke. Gas chromatographic analysis of naturally occurring cannabinoids: A review of literature published during the past decade. Phytochemical analysis : PCA. vol 31. issue 2. 2020-02-21. PMID:31469459. |
cannabinoids are organic compounds, natural or synthetic, that bind to the cannabinoid receptors and have similar pharmacological properties as produced by the cannabis plant, cannabis sativa. |
2020-02-21 |
2023-08-13 |
Not clear |
| Yedukondalu Nalli, Mohd Saleem Dar, Nasima Bano, Javeed Ur Rasool, Aminur R Sarkar, Junaid Banday, Aadil Qadir Bhat, Basit Rafia, Ram A Vishwakarma, Mohd Jamal Dar, Asif Al. Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain. Bioorganic & medicinal chemistry letters. vol 29. issue 9. 2020-02-19. PMID:30871771. |
since the canonical wnt/β-catenin signaling has recently been implicated in pain sensation, we investigated the impact of major cannabinoids (1-6) from the leaves of cannabis sativa and an epoxy derivative of compound 2, here upon referred to as 2a, on modulating wnt/β-catenin signaling pathway. |
2020-02-19 |
2023-08-13 |
Not clear |
| Josephine E Watson, Justin S Kim, Aditi Da. Emerging class of omega-3 fatty acid endocannabinoids & their derivatives. Prostaglandins & other lipid mediators. vol 143. 2020-02-19. PMID:31085370. |
these receptors are activated by cannabinoids, that include the active constituents of cannabis sativa, as well as endocannabinoids (ecbs). |
2020-02-19 |
2023-08-13 |
Not clear |
| Ricardo E Ramírez-Orozco, Ricardo García-Ruiz, Paula Morales, Carlos M Villalón, J Rafael Villafán-Bernal, Bruno A Marichal-Cancin. Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding. Current neuropharmacology. vol 17. issue 10. 2020-02-19. PMID:31146657. |
indeed, eating behaviour alterations in marijuana users have led to investigate the orexigenic/anorexigenic effects of cannabinoids in animal/ human models. |
2020-02-19 |
2023-08-13 |
human |
| b' Marilyn A Huestis, Renata Solimini, Simona Pichini, Roberta Pacifici, Jeremy Carlier, Francesco Paolo Busard\\xc3\\xb. Cannabidiol Adverse Effects and Toxicity. Current neuropharmacology. vol 17. issue 10. 2020-02-19. PMID:31161980.' |
currently, there is a great interest in the potential medical use of cannabidiol (cbd), a non-intoxicating cannabinoid. |
2020-02-19 |
2023-08-13 |
Not clear |
| b' Marilyn A Huestis, Renata Solimini, Simona Pichini, Roberta Pacifici, Jeremy Carlier, Francesco Paolo Busard\\xc3\\xb. Cannabidiol Adverse Effects and Toxicity. Current neuropharmacology. vol 17. issue 10. 2020-02-19. PMID:31161980.' |
the world health organization considers rescheduling cannabis and cannabinoids. |
2020-02-19 |
2023-08-13 |
Not clear |
| Michele Dei Cas, Eleonora Casagni, Anna Saccardo, Sebastiano Arnoldi, Craig Young, Stefano Scotti, Edgardo Vieira de Manicor, Veniero Gambaro, Gabriella Rod. The Italian panorama of cannabis light preparation: Determination of cannabinoids by LC-UV. Forensic science international. vol 307. 2020-02-18. PMID:31927249. |
the italian panorama of cannabis light preparation: determination of cannabinoids by lc-uv. |
2020-02-18 |
2023-08-13 |
human |
| Eike Blohm, Peter Sell, Mark Neavy. Cannabinoid toxicity in pediatrics. Current opinion in pediatrics. vol 31. issue 2. 2020-02-17. PMID:30694824. |
pediatricians and pediatric emergency medicine providers face new challenges in counseling both patients and their parents, diagnosing exploratory ingestions of cannabinoids in toddlers, and managing complications of prolonged, heavy cannabis use in adolescents. |
2020-02-17 |
2023-08-13 |
Not clear |